Bullous drug eruption in a patient with psoriasis after a test dose of methotrexate - 23/10/13
Doi : 10.1016/j.jaad.2013.07.012
Eric Y. Sako, BS a, Shannon Famenini, BS a, Jashin J. Wu, MD b, ⁎ 
a David Geffen School of Medicine at University of California–Los Angeles, Los Angeles
b Department of Dermatology, Kaiser Permanente Medical Center, Los Angeles
∗Correspondence to: Jashin J. Wu, MD, Department of Dermatology, Kaiser Permanente Medical Center, 1515 N Vermont Ave, 5th Floor, Los Angeles, CA 90027
| Funding sources: None. |
|
| Disclosure: Dr Wu received research funding from Abbott Laboratories, AbbVie, Amgen, and Pfizer, which were not directly related to this study. Mr Sako and Ms Famenini have no conflicts of interest to declare. |
© 2013
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 69 - N° 5
P. e264-e265 - novembre 2013 Retour au numéro
Article précédent
- Malignant perivascular epithelioid cell tumor: A case report of a cutaneous tumor on the cheek of a male patient
- Karin Greveling, Veronique J.L. Winnepenninckx, Ivo F. Nagtzaam, Martin Lacko, Stephania M.H. Tuinder, Jos M.A. de Jong, Nicole W.J. Kelleners-Smeets
- A maculopapular-type eruption associated with deferasirox administration
- Akifumi Ohshita, Noriaki Nakai, Norito Katoh, Keisuke Konishi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?